La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Versus Systems a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Versus Systems..

Versus Systems (NASDAQ:VS) Azioni, Catena delle Opzioni

Versus Systems

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

Versus Systems Inc

TCTM Kids IT Education Inc. - American Depositary Shares

TCTM Kids IT Education Inc

Vision Sensing Acquisition Corp Ordinary Shares - Class A

Vision Sensing Acquisition Corp

Vision Sensing Acquisition Corp Units (1 Ord Class A & 3/4 War)

Vision Sensing Acquisition Corp Warrants (21/10/2026)

VERSES AI INC CL A SUB VTG NO PAR

Viasat Inc

VITASPRING BIOMEDICAL CO by VitaSpring Biomedical Co. Ltd.

VitaSpring Biomedical Co Ltd

VSBLTY Groupe Technologies Corp

VSBLTY GROUPE TECHNOLOGIS by VSBLTY GROUPE TECHNOLOGIES CORP.

Viscofan SA

Victoria's Secret & Co

VictoryShares Dividend Accelerator ETF

Vanguard Malvern Funds Vanguard Short Duration Bond ETF

Vanguard Tax-Managed Funds Vanguard Short Duration Tax-Exempt Bond ETF

VSE Corp

VSee Health Inc

GREEN ECONOMY DEVELOPMENT by Green Economy Development Limited

Green Economy Development Ltd

VUSIONGROUP U/ADR by VUSIONGROUP

Vanguard ESG International Stock ETF

Vishay Intertechnology, Inc. Common Stock

Vishay Intertechnology Inc

Virtus Newfleet Short Duration High Yield Bond ETF

Vision Inc

Applied Finance Valuation Large Cap ETF

Vasamed Inc

VS Media Holdings Limited - Class A Ordinary Shares

VS Media Holdings Ltd

Verify Smart Corp

VictoryShares US Multi-Factor Minimum Volatility ETF

Verso

VISTA OIL & GAS SAB DE CV by Vista Energy S.A.B. de C.V.

Vista Energy SAB de CV

THREE SIXTY SOLAR LTD by THREE SIXTY SOLAR LTD.

Three Sixty Solar Ltd

Vesper

Viaspace Inc

VSPIKES Volatility of Volatility Index

VICTORY SQUARE TECH ORD by Victory Square Technologies Inc

Victory Square Technologies Inc

Voiceserve Inc

Vanguard FTSE All-Wld ex-US SmCp Idx ETF

VALID SOLUCOES S/ADR by Valid Solucoes S.A

Valid Solucoes SA

Visionstate Corp

Voice Assist Inc

Vistra Corp

Vasta Platform Limited - Class A Ordinary Shares

Vasta Platform Ltd

VISION TECHNOLOGY CORP by Vision Technology Corp.

Vision Technology Corp

Vast Renewables Ltd

Vast Renewables Ltd Warrants (01/07/2028)

VNV Global AB

Verastem Inc

VISTA OUTDOOR INC COM

Vestis Corp

VAST RENEWABLES LTD by Vast Renewables Limited

Vestum AB

VOSS VEKSEL OG LNDMNDSBNK by VOSS VEKSEL OG LANDMANDSBANK ASA

VSY - United States Dollar

VESYNC CO LTD by VESYNC CO LTD.

VISCOUNT SYSTEMS INC by Viscount Systems, Inc.

Viscount Systems Inc

v.systems

Venus SXP

Truist Securities analyst Brandon King maintains Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) with a Buy and raises the price target from $92 to $96.

News

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Western Alliance, Raises Price Target to $96

Wells Fargo analyst Michael Brown maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Underweight and raises the price target from $55 to $57.

Wells Fargo Maintains Underweight on Brookfield Asset Mgmt, Raises Price Target to $57

Truist Securities analyst Brian Foran maintains UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) with a Buy and raises the price target from $120 to $128.

UMBF

Truist Securities Maintains Buy on UMB Financial, Raises Price Target to $128

GLBKV

Trading Halt: Halt status updated at 9:40:00 AM ET: Quotation Resumption: New Issue Available

GLBAV

Trading Halt: Halt status updated at 9:40:02 AM ET: Quotation Resumption: New Issue Available

Wells Fargo analyst Michael Brown maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Equal-Weight and raises the price target from $153 to $167.

Wells Fargo Maintains Equal-Weight on Blackstone, Raises Price Target to $167

Wells Fargo analyst Michael Brown maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Overweight and raises the price target from $189 to $202.

ARES

Wells Fargo Maintains Overweight on Ares Management, Raises Price Target to $202

Wells Fargo analyst Michael Brown maintains Apollo Asset Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) with a Overweight and raises the price target from $160 to $173.

Wells Fargo Maintains Overweight on Apollo Asset Management, Raises Price Target to $173

Milestone&#xAE; Pharmaceuticals Inc. ("Milestone") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIST#NASDAQ">MIST</a>), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the pricing of its previously announced underwritten public offering (the "Offering") of (i) 31,500,000 of its common shares (the "Shares"), accompanying Series A common warrants (the "Series A Common Warrants") to purchase an aggregate of 31,500,000 common shares and accompanying Series B common warrants (the "Series B Common Warrants") to purchase an aggregate of 31,500,000 common shares , at a combined public offering price of $1.50 per share and accompanying Series A Common Warrant and Series B Common Warrant and (ii) in lieu of common shares to certain investors that so choose, pre-funded warrants to purchase 3,502,335 common shares, accompanying Series A Common Warrants to purchase an aggregate of 3,502,335 common shares and accompanying Series B Common Warrants to purchase an aggregate of 3,502,335 common shares, at a combined public offering price of $1.499 per pre-funded warrant and accompanying Series A Common Warrant and Series B Common Warrant, which represents the combined public offering price for the Shares and accompanying common warrants less the $0.001 per share exercise price for each such pre-funded warrant. The proceeds to Milestone from the Offering, before deducting underwriting commissions and offering expenses payable by Milestone, are expected to be approximately $52.5 million. The Offering is expected to close on or about July 14, 2025, subject to satisfaction of customary closing conditions.
Milestone intends to use the net proceeds from the Offering together with existing cash and cash equivalents, to fund the clinical development and commercial launch of etripamil in its lead indication of paroxysmal supraventricular tachycardia (PSVT), as well as for working capital and other general corporate purposes.

MIST

Milestone Pharma Prices $52.5M Equity Offering With Warrants; Offering Is Expected To Close On Or About July 14, 2025

Wells Fargo analyst Ike Boruchow maintains Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) with a Overweight and raises the price target from $22 to $25.

LEVI

Wells Fargo Maintains Overweight on Levi Strauss, Raises Price Target to $25

<a href="https://www.bloomberg.com/news/articles/2025-07-11/delta-strips-engines-off-new-airbus-jets-to-overcome-shortage?srnd=phx-economics-v2" title="https://www.bloomberg.com/news/articles/2025-07-11/delta-strips-engines-off-new-airbus-jets-to-overcome-shortage?srnd=phx-economics-v2">https://www.bloomberg.com/news/articles/2025-07-11/delta-strips-engines-off-new-airbus-jets-to-overcome-shortage?srnd=phx-economics-v2</a>

'Delta Strips Engines Off New Airbus Jets To Overcome US Shortage' - Bloomberg

United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) and Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) report that the US Department of Justice Antitrust Division announced yesterday that it has closed its investigation into the proposed transaction with T-Mobile. The transaction remains subject to approval by the Federal Communications Commission (FCC), and we continue to work with the FCC as they complete their independent assessment.

United States Cellular And Telephone And Data Systems Say US Department Of Justice Antitrust Division Closes Investigation Into Proposed Transaction With T-Mobile

Truist Securities analyst David Smith maintains Synovus Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) with a Buy and raises the price target from $56 to $60.

Truist Securities Maintains Buy on Synovus Financial, Raises Price Target to $60

Wells Fargo analyst Stephen Baxter downgrades Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) from Equal-Weight to Underweight and lowers the price target from $16 to $10.

Downgrades

OSCR

Wells Fargo Downgrades Oscar Health to Underweight, Lowers Price Target to $10

Truist Securities analyst Brandon King maintains Pinnacle Finl Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) with a Buy and raises the price target from $123 to $127.

PNFP

Truist Securities Maintains Buy on Pinnacle Finl Partners, Raises Price Target to $127

UBS analyst Joshua Spector downgrades Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) from Neutral to Sell and lowers the price target from $64 to $57.

UBS Downgrades Albemarle to Sell, Lowers Price Target to $57

Truist Securities analyst Brian Foran maintains Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) with a Buy and raises the price target from $26 to $27.

Truist Securities Maintains Buy on Old National, Raises Price Target to $27

General

ALTI

AlTi Global To Wind Down Non-Core International Real Estate Business

Truist Securities analyst David Smith maintains F N B (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNB#NYSE">FNB</a>) with a Buy and raises the price target from $16.5 to $17.5.

Truist Securities Maintains Buy on F N B, Raises Price Target to $17.5

<a href="https://www.reuters.com/sustainability/boards-policy-regulation/meta-wont-tweak-pay-or-consent-model-further-despite-risk-eu-fines-sources-say-2025-07-11/" title="https://www.reuters.com/sustainability/boards-policy-regulation/meta-wont-tweak-pay-or-consent-model-further-despite-risk-eu-fines-sources-say-2025-07-11/">https://www.reuters.com/sustainability/boards-policy-regulation/meta-wont-tweak-pay-or-consent-model-further-despite-risk-eu-fines-sources-say-2025-07-11/</a>

Comments

Versus Systems

Versus Systems (VS) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO